Chemoinformaics analysis of 9-Acetamido-3,4-Dihydropyrido-(3,4-B)-Indole
| Molecular Weight | 227.267 | nRot | 1 |
| Heavy Atom Molecular Weight | 214.163 | nRig | 16 |
| Exact Molecular Weight | 227.106 | nRing | 3 |
| Solubility: LogS | -3.419 | nHRing | 2 |
| Solubility: LogP | 2.247 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 34.4803 |
| nHD | 1 | BPOL | 16.1897 |
| QED | 0.792 |
| Synth | 3.086 |
| Natural Product Likeliness | -0.087 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.982 |
| HIA | 0.01 |
| CACO-2 | -4.972 |
| MDCK | 0.0000202 |
| BBB | 0.947 |
| PPB | 0.865884 |
| VDSS | 1.487 |
| FU | 0.19644 |
| CYP1A2-inh | 0.941 |
| CYP1A2-sub | 0.96 |
| CYP2c19-inh | 0.133 |
| CYP2c19-sub | 0.701 |
| CYP2c9-inh | 0.03 |
| CYP2c9-sub | 0.563 |
| CYP2d6-inh | 0.073 |
| CYP2d6-sub | 0.859 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.569 |
| CL | 4.755 |
| T12 | 0.877 |
| hERG | 0.009 |
| Ames | 0.944 |
| ROA | 0.13 |
| SkinSen | 0.14 |
| Carcinogencity | 0.967 |
| EI | 0.024 |
| Respiratory | 0.862 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.743103 |